News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Daiichi Suntory Pharma Co., Ltd. to Move Clot Prevention Drug to Phase 3


10/31/2008 6:30:06 AM

TOKYO, Oct 31 (Reuters) - Japanese drugmaker Daiichi Sankyo Co Ltd said on Friday it would advance its DU-176b clot prevention drug to Phase III trials, the final stage before marketing approval, in November.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES